Skip to main content

Table 6 In vitro activity of cyadox, quinocetone and mequindox in combination with various antibacterials against Mycobacterium tuberculosis complex

From: In vitro antimicrobial activities of animal-used quinoxaline 1,4-di-N-oxides against mycobacteria, mycoplasma and fungi

Drug combination

M. bovis ATCC 19210

M. tb H37Rv ATCC 27294

FICA + FICB

FIC

Combined effect

FICA + FICB

FIC

Combined effect

CYA + Rifampicin

0.5 + 0.25

0.75

additive

0.5 + 0.25

0.75

additive

CYA + Isoniazide

1 + 0.5

1.5

indifferent

1 + 0.25

1.25

indifferent

CYA + Streptomycin

0.5 + 0.25

0.75

additive

0.5 + 0.5

1

additive

CYA + Kanamycin

1 + 0.5

1.25

indifferent

1 + 0.5

1.5

indifferent

CYA + Ethambutol

1 + 0.5

1.5

indifferent

1 + 0.25

1.25

indifferent

CYA + Amikacin

1 + 0.5

1.5

indifferent

1 + 0.25

1.25

indifferent

QCT + Rifampicin

0.5 + 0.5

1

additive

0.5 + 0.25

0.75

additive

QCT + Isoniazide

1 + 0.5

1.5

indifferent

1 + 0.25

1.25

indifferent

QCT + Streptomycin

0.5 + 0.5

1

additive

1 + 0.25

1.25

indifferent

QCT + Kanamycin

1 + 0.5

1.25

indifferent

1 + 0.5

1.5

additive

QCT + Ethambutol

1 + 0.5

1.5

indifferent

1 + 0.25

1.25

indifferent

QCT + Amikacin

0.5 + 0.5

1

additive

1 + 0.5

1.5

indifferent

MEQ + Rifampicin

0.5 + 0.5

1

additive

0.5 + 0.25

0.75

additive

MEQ + Isoniazide

1 + 0.5

1.5

indifferent

1 + 0.25

1.25

indifferent

MEQ + Streptomycin

1 + 0.5

1.55

additive

1 + 0.5

1.5

additive

MEQ + Kanamycin

1 + 0.5

1.5

indifferent

0.5 + 0.5

1

additive

MEQ + Ethambutol

1 + 0.5

1.5

indifferent

1 + 0.5

1.5

indifferent

MEQ + Amikacin

1 + 0.5

1.55

indifferent

1 + 0.5

1.5

indifferent